Evidence map›Paper›PMID 25756965›Full record

ArticlePloS one2015

Changes in protein expression in two cholangiocarcinoma cell lines undergoing formation of multicellular tumor spheroids in vitro.

Carlo Mischiati, Blendi Ura, Leda Roncoroni, Luca Elli, Carlo Cervellati, Monica Squerzanti, Dario Conte, Luisa Doneda, Patrizia Polverino de Laureto, Giorgia de Franceschi and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. 3D cancer models: One step closer toFrontiers in immunology · 2023
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 2 countries.

Carlo MischiatiDepartment of Biomedical and Surgical Sciences, University of Ferrara, Ferrara, Italy.
Blendi UraInstitute for Maternal and Child Health, IRCCS Burlo Garofalo, University of Trieste, Trieste, Italy.
Leda RoncoroniCenter for Prevention and Diagnosis of Coeliac Disease/Gastroenterology 2, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milano, Italy; Department of Biomedical, Surgical and Odontoiatric Sciences, University of Milano, Milano, Italy.
Luca ElliCenter for Prevention and Diagnosis of Coeliac Disease/Gastroenterology 2, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milano, Italy.
Carlo CervellatiDepartment of Biomedical and Surgical Sciences, University of Ferrara, Ferrara, Italy.
Monica SquerzantiDepartment of Biomedical and Surgical Sciences, University of Ferrara, Ferrara, Italy.
Dario ConteCenter for Prevention and Diagnosis of Coeliac Disease/Gastroenterology 2, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milano, Italy.
Luisa DonedaDepartment of Biomedical, Surgical and Odontoiatric Sciences, University of Milano, Milano, Italy.
Patrizia Polverino de LauretoCRIBI Centre of Innovative Biotechnologies, University of Padua, Padua, Italy.
Giorgia de FranceschiCRIBI Centre of Innovative Biotechnologies, University of Padua, Padua, Italy.
Roberta CalzaDepartment of Biomedical and Surgical Sciences, University of Ferrara, Ferrara, Italy.
Carlos A BarreroMoulder Center for Drug Discovery Research, Temple University, School of Pharmacy, Philadelphia, Pennsylvania, United States of America.
Salim MeraliMoulder Center for Drug Discovery Research, Temple University, School of Pharmacy, Philadelphia, Pennsylvania, United States of America.
Carlo FerrariDepartment of Clinical and Molecular Sciences, Faculty of Medicine, Le Marche Polytechnic University, Ancona, Italy.
Carlo M BergaminiDepartment of Biomedical and Surgical Sciences, University of Ferrara, Ferrara, Italy.
Enzo AgostinelliIstituto Pasteur, Fondazione Cenci Bolognetti and Department of Biochemical Sciences "A. Rossi Fanelli", La Sapienza University of Rome and CNR, Biology and Molecular Pathology Institutes, Rome, Italy.
University of Ferrara · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITTemple University · USUniversity of Padua · ITIstituto Pasteur · ITMarche Polytechnic University · ITUniversity of Milan · ITUniversity of Trieste · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epithelial-to-Mesenchymal Transition (EMT) is relevant in malignant growth and frequently correlates with worsening disease progression due to its implications in metastases and resistance to therapeutic interventions. Although EMT is known to occur in several types of solid tumors, the information concerning tumors arising from the epithelia of the bile tract is still limited. In order to approach the problem of EMT in cholangiocarcinoma, we decided to investigate the changes in protein expression occurring in two cell lines under conditions leading to growth as adherent monolayers or to formation of multicellular tumor spheroids (MCTS), which are considered culture models that better mimic the growth characteristics of in-vivo solid tumors. In our system, changes in phenotypes occur with only a decrease in transmembrane E-cadherin and vimentin expression, minor changes in the transglutaminase protein/activity but with significant differences in the proteome profiles, with declining and increasing expression in 6 and in 16 proteins identified by mass spectrometry. The arising protein patterns were analyzed based on canonical pathways and network analysis. These results suggest that significant metabolic rearrangements occur during the conversion of cholangiocarcinomas cells to the MCTS phenotype, which most likely affect the carbohydrate metabolism, protein folding, cytoskeletal activity, and tissue sensitivity to oxygen.

Indexed as

Gene Expression Regulation, NeoplasticBile Duct NeoplasmsCell Line, TumorCholangiocarcinomaEpithelial-Mesenchymal TransitionHumansProteomeSpheroids, CellularProteome

Identifiers

PMID25756965
PMCPMC4355290
OpenAlexW2093968314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.